D. Broekhoven, . Van, D. Grünhagen, M. Bakker, T. Dalen et al., Time Trends in the Incidence and Treatment of Extra-Abdominal and Abdominal Aggressive Fibromatosis: A Population-Based Study, Annals of Surgical Oncology, vol.51, issue.2, pp.2817-2840, 2015.
DOI : 10.1016/j.ejca.2014.11.005

J. Reitamo, P. Häyry, E. Nykyri, and E. Saxén, The Desmoid Tumor. I.: Incidence, Sex-, Age- and Anatomical Distribution in the Finnish Population, American Journal of Clinical Pathology, vol.77, issue.6, pp.665-73, 1982.
DOI : 10.1093/ajcp/77.6.665

N. Penel, J. Coindre, S. Bonvalot, A. Italiano, A. Neuville et al., Management of desmoid tumours: A nationwide survey of labelled reference centre networks in France, European Journal of Cancer, vol.58, pp.90-96, 1990.
DOI : 10.1016/j.ejca.2016.02.008

URL : https://hal.archives-ouvertes.fr/hal-01812682

V. Jo and C. Fletcher, WHO classification of soft tissue tumours: an update based on the 2013 (4th) edition. Pathology (Phila) 2014 Feb, pp.95-104

L. Guellec, S. Soubeyran, I. Rochaix, P. Filleron, T. Neuville et al., CTNNB1 mutation analysis is a useful tool for the diagnosis of desmoid tumors: a study of 260 desmoid tumors and 191 potential morphologic mimics, Modern Pathology, vol.126, issue.12, pp.1551-1559, 2012.
DOI : 10.1016/j.humpath.2006.01.017

C. Colombo, S. Bolshakov, S. Hajibashi, L. Lopez-terrada, W. Wang et al., mutational analysis, Histopathology, vol.36, issue.2, pp.336-376, 2011.
DOI : 10.1016/j.humpath.2005.03.005

S. Salas, A. Dufresne, B. Bui, J. Blay, P. Terrier et al., Prognostic Factors Influencing Progression-Free Survival Determined From a Series of Sporadic Desmoid Tumors: A Wait-and-See Policy According to Tumor Presentation, Journal of Clinical Oncology, vol.29, issue.26, pp.3553-3561, 2011.
DOI : 10.1200/JCO.2010.33.5489

M. Nieuwenhuis, M. Casparie, L. Mathus-vliegen, O. Dekkers, P. Hogendoorn et al., A nation-wide study comparing sporadic and familial adenomatous polyposis-related desmoid-type fibromatoses, International Journal of Cancer, vol.38, issue.1
DOI : 10.1136/jmg.38.12.861

URL : http://onlinelibrary.wiley.com/doi/10.1002/ijc.25664/pdf

, Int J Cancer, vol.129, issue.1, pp.256-61, 2011.

T. Fallen, M. Wilson, B. Morlan, and N. Lindor, Desmoid Tumors ??? a Characterization of Patients Seen at Mayo Clinic 1976???1999, Familial Cancer, vol.4, issue.3, pp.191-195, 2006.
DOI : 10.1001/archsurg.1979.01370340087015

L. Koskenvuo, A. Ristimäki, A. Lepistö, N. Penel, L. Cesne et al., Comparison of sporadic and FAP-associated desmoid-type fibromatoses Surgical versus non-surgical approach in primary desmoid-type fibromatosis patients: A nationwide prospective cohort from the French Sarcoma Group, J Surg Oncol. Eur J Cancer Oxf Engl, vol.1183, pp.125-156, 1990.

A. Crago, B. Denton, S. Salas, A. Dufresne, J. Mezhir et al., A Prognostic Nomogram for Prediction of Recurrence in Desmoid Fibromatosis, Annals of Surgery, vol.258, issue.2, pp.347-53, 2013.
DOI : 10.1097/SLA.0b013e31828c8a30

S. Bonvalot, N. Ternès, M. Fiore, G. Bitsakou, C. Colombo et al., Spontaneous Regression of Primary Abdominal Wall Desmoid Tumors: More Common than Previously Thought, Annals of Surgical Oncology, vol.173, issue.Suppl 10, 2013.
DOI : 10.2353/ajpath.2008.080475

M. Fiore, F. Rimareix, L. Mariani, J. Domont, P. Collini et al., Desmoid-Type Fibromatosis: A Front-Line Conservative Approach to Select Patients for Surgical Treatment, Annals of Surgical Oncology, vol.173, issue.9, 2009.
DOI : 10.1016/j.ijrobp.2007.10.013

C. Colombo, R. Miceli, L. Péchoux, C. Palassini, E. Honoré et al., Sporadic extra abdominal wall desmoid-type fibromatosis: Surgical resection can be safely limited to a minority of patients, European Journal of Cancer, vol.51, issue.2, pp.186-92, 1990.
DOI : 10.1016/j.ejca.2014.11.019

M. Fiore, A. Macneill, A. Gronchi, and C. Colombo, Desmoid-Type Fibromatosis, Surgical Oncology Clinics of North America, vol.25, issue.4, pp.803-829, 2016.
DOI : 10.1016/j.soc.2016.05.010

B. Kasper, C. Baumgarten, J. Garcia, S. Bonvalot, R. Haas et al., An update on the management of sporadic desmoid-type fibromatosis: a European Consensus Initiative between Sarcoma PAtients EuroNet (SPAEN) and European Organization for Research and Treatment of Cancer (EORTC)/Soft Tissue and Bone Sarcoma Group (STBSG), Annals of Oncology, vol.18, issue.4, pp.2399-408, 2017.
DOI : 10.1634/theoncologist.2012-0449

B. Kasper, C. Baumgarten, S. Bonvalot, R. Haas, F. Haller et al., Management of sporadic desmoid-type fibromatosis: A European consensus approach based on patients??? and professionals??? expertise ??? A Sarcoma Patients EuroNet and European Organisation for Research and Treatment of Cancer/Soft Tissue and Bone Sarcoma Group initiative, European Journal of Cancer, vol.51, issue.2, pp.127-163, 1990.
DOI : 10.1016/j.ejca.2014.11.005

M. Callstrom and A. Kurup, Percutaneous ablation for bone and soft tissue metastases--why cryoablation? Skeletal Radiol, pp.835-844, 2009.

J. Kujak, P. Liu, G. Johnson, and M. Callstrom, Early experience with percutaneous cryoablation of extra-abdominal desmoid tumors, Skeletal Radiology, vol.189, issue.2, pp.175-82, 2010.
DOI : 10.2214/ajr.160.4.8456670

M. Havez, N. Lippa, S. Al-ammari, M. Kind, E. Stoeckle et al., Percutaneous Image-Guided Cryoablation in Inoperable Extra-abdominal Desmoid Tumors: A Study of Tolerability and Efficacy, CardioVascular and Interventional Radiology, vol.147, issue.5, pp.1500-1506, 2014.
DOI : 10.1016/j.surg.2009.10.053

J. Schmitz, G. Schmit, T. Atwell, M. Callstrom, A. Kurup et al., Percutaneous Cryoablation of Extraabdominal Desmoid Tumors: A 10-Year Experience, American Journal of Roentgenology, vol.207, issue.1, 2016.
DOI : 10.2214/AJR.15.14391

M. Ahmed, L. Solbiati, C. Brace, D. Breen, M. Callstrom et al., Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update, Radiology, 2014.
DOI : 10.1016/j.jvir.2014.08.027

S. Kawamoto, S. Solomon, D. Bluemke, and E. Fishman, Computed Tomography and Magnetic Resonance Imaging Appearance of Renal Neoplasms After Radiofrequency Ablation and Cryoablation, Seminars in Ultrasound, CT and MRI, vol.30, issue.2, pp.67-77, 2009.
DOI : 10.1053/j.sult.2008.12.005

G. Wile, J. Leyendecker, K. Krehbiel, R. Dyer, and R. Zagoria, CT and MR imaging after imaging-guided thermal ablation of renal neoplasms. Radiogr Rev Publ Radiol Soc N Am Inc, pp.325-339, 2007.
DOI : 10.1148/rg.272065083

J. Garnon, G. Koch, J. Caudrelier, G. Tsoumakidou, R. Cazzato et al., Expanding the borders: Imageguided procedures for the treatment of musculoskeletal tumors. Diagn Interv Imaging, pp.635-679, 2017.

P. Ghanouni, A. Dobrotwir, A. Bazzocchi, M. Bucknor, R. Bitton et al., Magnetic resonanceguided focused ultrasound treatment of extra-abdominal desmoid tumors: a retrospective multicenter study
DOI : 10.1007/s00330-016-4376-5

URL : http://europepmc.org/articles/pmc5097700?pdf=render

, 2017 Feb, Eur Radiol, vol.27, issue.2, pp.732-772

R. Keus, R. Nout, J. Blay, J. Jong, I. Hennig et al., Results of a phase II pilot study of moderate dose radiotherapy for inoperable desmoid-type fibromatosis--an EORTC STBSG and ROG study (EORTC 62991-22998), Annals of Oncology, vol.9, issue.4, pp.2672-2678, 2013.
DOI : 10.1586/era.09.9

N. Penel, F. Chibon, and S. Salas, Adult desmoid tumors, Current Opinion in Oncology, vol.29, issue.4, pp.268-74
DOI : 10.1097/CCO.0000000000000374

URL : https://hal.archives-ouvertes.fr/hal-01741724

D. Quast, R. Schneider, E. Burdzik, S. Hoppe, and G. Möslein, Long-term outcome of sporadic and FAPassociated desmoid tumors treated with high-dose selective estrogen receptor modulators and sulindac: a single-center long-term observational study in 134 patients. Fam Cancer, pp.31-40, 2016.

E. Palassini, A. Frezza, L. Mariani, L. Lalli, C. Colombo et al., Long-term Efficacy of Methotrexate Plus Vinblastine/Vinorelbine in a Large Series of Patients Affected by Desmoid-Type Fibromatosis, The Cancer Journal, vol.23, issue.2, pp.86-91
DOI : 10.1097/PPO.0000000000000254

B. Kasper, V. Gruenwald, P. Reichardt, S. Bauer, G. Rauch et al., Imatinib induces sustained progression arrest in RECIST progressive desmoid tumours: Final results of a phase II study of the German Interdisciplinary Sarcoma Group (GISG), European Journal of Cancer, vol.76, pp.60-67, 1990.
DOI : 10.1016/j.ejca.2017.02.001

N. Penel, L. Cesne, A. Bui, B. Perol, D. Brain et al., Imatinib for progressive and recurrent aggressive fibromatosis (desmoid tumors): an FNCLCC/French Sarcoma Group phase II trial with a long-term follow-up, Annals of Oncology, vol.23, issue.29, pp.452-459, 2011.
DOI : 10.1200/JCO.2005.02.8712

C. Mueller, R. Croner, P. Klein, R. Grützmann, and N. Vassos, Primary and recurrent sporadic desmoids

, Prognostic factors influencing recurrence-free survival after complete gross resection, Int J Surg Lond Engl. 2016, vol.31, pp.63-70

C. Colombo, R. Miceli, A. Lazar, F. Perrone, R. Pollock et al., CTNNB1 45F mutation is a molecular prognosticator of increased postoperative primary desmoid tumor recurrence, Cancer, vol.16, issue.20, pp.3696-702, 2013.
DOI : 10.1245/s10434-009-0586-2

R. 1. Stiller, C. Trama, A. Serraino, D. Rossi, S. Navarro et al., Descriptive epidemiology of sarcomas in Europe: report from the RARECARE project, Eur J Cancer Oxf Engl, 1990.

, Feb, vol.49, issue.3, pp.684-95

V. Jo and C. Fletcher, WHO classification of soft tissue tumours: an update based on the 2013 (4th) edition. Pathology (Phila) 2014 Feb, pp.95-104

J. Toro, L. Travis, H. Wu, K. Zhu, C. Fletcher et al., Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program

, An analysis of 26,758 cases, Int J Cancer Dec, vol.15119, issue.12, pp.2922-2952, 2006.

N. Penel, J. Coindre, G. A. Terrier, P. Ranchere-vince, D. Collin et al., Presentation and outcome of frequent and rare sarcoma histologic subtypes: A study of 10,262 patients with localized visceral/soft tissue sarcoma managed in reference centers, Cancer, vol.27, issue.suppl 6, 2017.
DOI : 10.1200/JCO.2015.60.8505

J. Coindre, P. Terrier, N. Bui, F. Bonichon, C. F. et al., Prognostic factors in adult patients with locally controlled soft tissue sarcoma. A study of 546 patients from the French Federation of Cancer Centers Sarcoma Group., Journal of Clinical Oncology, vol.14, issue.3, pp.869-77, 1996.
DOI : 10.1200/JCO.1996.14.3.869

M. Sant, C. Allemani, M. Santaquilani, A. Knijn, F. Marchesi et al.,

, Survival of cancer patients diagnosed in 1995-1999. Results and commentary, Eur J Cancer Oxf Engl, vol.45, issue.6, pp.931-91, 1990.

J. Blay, P. Soibinet, N. Penel, E. Bompas, F. Duffaud et al., Improved survival using specialized multidisciplinary board in sarcoma patients, Annals of Oncology, vol.41, issue.2, pp.2852-2861, 2017.
DOI : 10.1016/j.ejso.2015.04.002

N. Berger, J. Silva, H. Mogal, C. Clarke, M. Bedi et al., Overall survival after resection of retroperitoneal sarcoma at academic cancer centers versus community cancer centers: An analysis of the National Cancer Data Base, Surgery, vol.163, issue.2, 2017.
DOI : 10.1016/j.surg.2017.07.009

E. Stoeckle, A. Michot, B. Henriques, P. Sargos, C. Honoré et al., Surgery for soft-tissue sarcomas of the limbs and trunk wall], Cancer Radiother J Soc Francaise Radiother Oncol, vol.20, pp.6-7657, 2016.

S. Bonvalot, F. Rimareix, S. Causeret, L. Péchoux, C. Boulet et al., Hyperthermic Isolated Limb Perfusion in Locally Advanced Soft Tissue Sarcoma and Progressive Desmoid-Type Fibromatosis with TNF 1??mg and Melphalan (T1-M HILP) Is Safe and Efficient, Annals of Surgical Oncology, vol.13, issue.9325, pp.3350-3357, 2009.
DOI : 10.1016/j.ejso.2008.01.007

L. Thomas, M. Delannes, E. Stöckle, P. Martel, B. Bui et al., Intraoperative interstitial iridium brachytherapy in the management of soft tissue sarcomas: preliminary results of a feasibility phase II study, Radiotherapy and Oncology, vol.33, issue.2, pp.99-105, 1994.
DOI : 10.1016/0167-8140(94)90062-0

R. Trans-atlantic and . Group, Management of Recurrent Retroperitoneal Sarcoma (RPS) in the Adult: A Consensus Approach from the Trans-Atlantic RPS Working Group, Annals of Surgical Oncology, vol.14, issue.6, pp.3531-3571, 2016.
DOI : 10.1586/14737140.2014.885840

J. Yang, S. Kong, H. Ahn, H. Lee, S. Jeong et al., Prognostic factors for reoperation of recurrent retroperitoneal sarcoma: The role of clinicopathological factors other than histologic grade, Journal of Surgical Oncology, vol.210, issue.2, pp.165-72, 2015.
DOI : 10.1016/j.jamcollsurg.2009.12.024

J. Park, L. Qin, F. Prete, C. Antonescu, M. Brennan et al., Predicting Outcome by Growth Rate of Locally Recurrent Retroperitoneal Liposarcoma, Annals of Surgery, vol.250, issue.6, 2009.
DOI : 10.1097/SLA.0b013e3181b2468b

A. Falk, L. Moureau-zabotto, M. Ouali, N. Penel, A. Italiano et al., Effect on Survival of Local Ablative Treatment of Metastases from Sarcomas: A Study of the French Sarcoma Group, Clinical Oncology, vol.27, issue.1, pp.48-55
DOI : 10.1016/j.clon.2014.09.010

S. Kawamoto, S. Solomon, D. Bluemke, and E. Fishman, Computed Tomography and Magnetic Resonance Imaging Appearance of Renal Neoplasms After Radiofrequency Ablation and Cryoablation, Seminars in Ultrasound, CT and MRI, vol.30, issue.2, pp.67-77, 2009.
DOI : 10.1053/j.sult.2008.12.005

G. Wile, J. Leyendecker, K. Krehbiel, R. Dyer, and R. Zagoria, CT and MR imaging after imagingguided thermal ablation of renal neoplasms. Radiogr Rev Publ Radiol Soc N Am Inc, pp.325-339, 2007.

J. Garnon, G. Koch, J. Caudrelier, G. Tsoumakidou, R. Cazzato et al., Expanding the borders

, Image-guided procedures for the treatment of musculoskeletal tumors. Diagn Interv Imaging, 2017.

C. Bellera, N. Penel, M. Ouali, S. Bonvalot, P. Casali et al., Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)???, Annals of Oncology, vol.30, issue.(Suppl 2), pp.865-72, 2015.
DOI : 10.1200/JCO.2011.37.0890

URL : https://hal.archives-ouvertes.fr/hal-01912106

S. Thompson, J. Schmitz, G. Schmit, M. Callstrom, and A. Kurup, Image-Guided Thermal Ablative Therapies in the Treatment of Sarcoma, Current Treatment Options in Oncology, vol.27, issue.1, p.25
DOI : 10.1016/j.clon.2014.09.010

T. Sato, T. Iguchi, T. Hiraki, H. Gobara, H. Fujiwara et al., Radiofrequency ablation of pulmonary metastases from sarcoma: single-center retrospective evaluation of 46 patients, Japanese Journal of Radiology, vol.33, issue.2, pp.61-68, 2017.
DOI : 10.1007/s00270-009-9730-4

M. Callstrom and A. Kurup, Percutaneous ablation for bone and soft tissue metastases--why cryoablation? Skeletal Radiol, pp.835-844, 2009.
DOI : 10.1007/s00256-009-0736-4

URL : https://link.springer.com/content/pdf/10.1007%2Fs00256-009-0736-4.pdf

J. Hinshaw, M. Lubner, T. Ziemlewicz, F. Lee, and C. Brace,

. Microwave, Radiofrequency, or Cryoablation?What Should You Use and Why? Radiographics, 2014.

E. Stoeckle, G. Kantor, L. Thomas, J. Coindre, and B. Bui, Surgery of recurrent soft tissue sarcoma of the extremities and the trunk wall: a comparison to primary sarcoma], Bull Cancer, 2004.

A. Daigeler, I. Zmarsly, T. Hirsch, O. Goertz, H. Steinau et al., Long-term outcome after local recurrence of soft tissue sarcoma: a retrospective analysis of factors predictive of survival in 135 patients with locally recurrent soft tissue sarcoma, British Journal of Cancer, vol.90, issue.6, pp.1456-64, 2014.
DOI : 10.1002/cncr.11365

A. Stojadinovic, D. Leung, P. Allen, J. Lewis, D. Jaques et al., Primary Adult Soft Tissue Sarcoma: Time-Dependent Influence of Prognostic Variables, Journal of Clinical Oncology, vol.20, issue.21, pp.4344-52, 2002.
DOI : 10.1200/JCO.2002.07.154

G. Gravel, S. Yevich, L. Tselikas, O. Mir, C. Teriitehau et al., Percutaneous thermal ablation: A new treatment line in the multidisciplinary management of metastatic leiomyosarcoma?, European Journal of Surgical Oncology (EJSO), vol.43, issue.1, pp.181-188, 2017.
DOI : 10.1016/j.ejso.2016.06.391

A. Gage, History of cryosurgery, Seminars in Surgical Oncology, vol.166, issue.2, pp.99-109, 1998.
DOI : 10.2214/ajr.166.4.8610562

H. Allington, Liquid nitrogen in the treatment of skin diseases, Calif Med, vol.72, issue.3, pp.153-158, 1950.

I. Cooper, . Cryobiology, . Viewed, . By, . Surgeon et al., , pp.44-51, 1964.

G. Garamy, Engineering aspects of cryosurgical instruments employing liquid nitrogen, Int Ophthalmol Clin, vol.7, issue.2, pp.283-308, 1967.

I. Copper, Cryogenic Surgery, New England Journal of Medicine, vol.268, issue.14, pp.743-752, 1963.
DOI : 10.1056/NEJM196304042681401

S. Stellar and I. Cooper, Mortality and Morbidity in Cryothalamectomy for Parkinsonism, Journal of Neurosurgery, vol.15, issue.5, pp.459-67, 1968.
DOI : 10.1111/j.1532-5415.1967.tb05328.x

W. Soanes and M. Gonder, Cryosurgery in benign and malignant diseases of the prostate, Int Surg. Feb, vol.51, issue.2, pp.104-120, 1969.

C. Yantorno, W. Soanes, M. Gonder, and S. Shulman, Studies in cryo-immunology. I. The production of antibodies to urogenital tissue in consequence of freezing treatment, Immunology, 1967.

W. Soanes, R. Ablin, and M. Gonder, Remission of Metastatic Lesions Following Cryosurgery in Prostatic Cancer: Immunologic Considerations, The Journal of Urology, vol.104, issue.1, pp.154-163, 1970.
DOI : 10.1016/S0022-5347(17)61690-2

P. Hewitt, J. Zhao, J. Akhter, and D. Morris, A Comparative Laboratory Study of Liquid Nitrogen and Argon Gas Cryosurgery Systems, Cryobiology, vol.35, issue.4, pp.303-311, 1997.
DOI : 10.1006/cryo.1997.2039

J. Rewcastle, G. Sandison, J. Saliken, B. Donnelly, and J. Mckinnon, Considerations during clinical operation of two commercially available cryomachines, Journal of Surgical Oncology, vol.37, issue.2, pp.106-117, 1999.
DOI : 10.1001/archsurg.1971.01350010047012

X. Buy, H. Lang, J. Garnon, and A. Gangi, Thermoablation percutan??e des cancers r??naux??: radiofr??quence ou cryoablation???, Journal de Radiologie, vol.92, issue.9, pp.774-88, 2011.
DOI : 10.1016/j.jradio.2011.07.016

D. C. Theodorescu and . Cryotherapy, Evolution and Biology. Rev Urol, vol.6, pp.9-19, 2004.

J. Baust, A. Gage, B. Johansen, T. Baust, and J. , Mechanisms of cryoablation: Clinical consequences on malignant tumors, Cryobiology, vol.68, issue.1, pp.1-11, 2014.
DOI : 10.1016/j.cryobiol.2013.11.001

A. Sidana, Cancer immunotherapy using tumor cryoablation, Immunotherapy, vol.13, issue.1, pp.85-93, 2014.
DOI : 10.1016/j.vaccine.2011.11.080

M. Brok, R. Sutmuller, R. Van-der-voort, E. Bennink, C. Figdor et al., In situ tumor ablation creates an antigen source for the generation of antitumor immunity. Cancer Res, pp.4024-4033, 2004.

W. Ngwa, O. Irabor, J. Schoenfeld, J. Hesser, S. Demaria et al., Using immunotherapy to boost the abscopal effect, Nature Reviews Cancer, vol.1, issue.5, 2018.
DOI : 10.1007/s11095-010-0176-9

K. Tatsutani, B. Rubinsky, G. Onik, and R. Dahiya, Effect of thermal variables on frozen human primary prostatic adenocarcinoma cells, Urology, vol.48, issue.3, pp.441-448, 1996.
DOI : 10.1016/S0090-4295(96)00199-9

A. Gage, J. Baust, and J. Baust, Experimental Cryosurgery Investigations In Vivo. Cryobiology, vol.59, issue.3, p.229, 2009.

A. Gage and J. Baust, Mechanisms of Tissue Injury in Cryosurgery, Cryobiology, vol.37, issue.3, pp.171-86, 1998.
DOI : 10.1006/cryo.1998.2115

A. Gage, K. Guest, M. Montes, J. Caruana, and D. Whalen, Effect of varying freezing and thawing rates in experimental cryosurgery, Cryobiology, vol.22, issue.2, pp.175-82, 1985.
DOI : 10.1016/0011-2240(85)90172-5

W. Gill, J. Fraser, and D. Carter, Repeated Freeze???Thaw Cycles in Cryosurgery, Nature, vol.5, issue.5152, pp.410-413, 1968.
DOI : 10.1085/jgp.45.3.545

A. Gangi, G. Tsoumakidou, X. Buy, and E. Quoix, Quality Improvement Guidelines for Bone Tumour Management, CardioVascular and Interventional Radiology, vol.32, issue.Suppl, pp.706-719, 2010.
DOI : 10.1097/01.RVI.0000133535.16753.58

J. Haaga and S. Beale, Use of CO2 to move structures as an aid to percutaneous procedures., Radiology, vol.161, issue.3, pp.829-859, 1986.
DOI : 10.1148/radiology.161.3.3097752

X. Buy, C. Tok, D. Szwarc, G. Bierry, and A. Gangi, Thermal Protection During Percutaneous Thermal Ablation Procedures: Interest of Carbon Dioxide Dissection and Temperature Monitoring, CardioVascular and Interventional Radiology, vol.39, issue.3, pp.529-563, 2009.
DOI : 10.2214/ajr.183.1.1830197

D. Filippiadis, S. Tutton, A. Mazioti, and A. Kelekis, Percutaneous image-guided ablation of bone and soft tissue tumours: a review of available techniques and protective measures, Insights into Imaging, vol.111, issue.10, pp.339-385, 2014.
DOI : 10.1177/159101991301900217

A. Kam, P. Littrup, M. Walther, J. Hvizda, and B. Wood, Thermal Protection during Percutaneous Thermal Ablation of Renal Cell Carcinoma, Journal of Vascular and Interventional Radiology, vol.15, issue.7, pp.753-761, 2004.
DOI : 10.1097/01.RVI.0000133535.16753.58

P. Rose and J. Morris, Cryosurgery/cryoablation in musculoskeletal neoplasms: history and state of the art, Current Reviews in Musculoskeletal Medicine, vol.25, issue.4, pp.353-60, 2015.
DOI : 10.1016/j.jvir.2014.08.006

A. Tomasian, A. Wallace, and J. Jennings, Benign Spine Lesions: Advances in Techniques for Minimally Invasive Percutaneous Treatment, American Journal of Neuroradiology, vol.15, issue.5, pp.852-61, 2017.
DOI : 10.1016/j.jvir.2014.08.006

B. Wu, Y. Xiao, X. Zhang, L. Zhao, and J. Carrino, CT-guided percutaneous cryoablation of osteoid osteoma in children: an initial study, Skeletal Radiology, vol.2, issue.1, pp.1303-1313, 2011.
DOI : 10.1146/annurev.bioeng.2.1.257

E. Santiago, V. Pauly, G. Brun, D. Guenoun, P. Champsaur et al., Percutaneous cryoablation for the treatment of osteoid osteoma in the adult population, European Radiology, vol.44, issue.6, 2018.
DOI : 10.1007/s00256-014-2061-9

URL : https://hal.archives-ouvertes.fr/hal-01960528

G. Tsoumakidou, C. Too, J. Garnon, J. Steib, and A. Gangi, Treatment of a spinal aneurysmal bone cyst using combined image-guided cryoablation and cementoplasty, Skeletal Radiology, vol.36, issue.6, 2015.
DOI : 10.1007/s00270-013-0641-z

, Feb, vol.44, issue.2, pp.285-294

M. Callstrom, D. Dupuy, S. Solomon, R. Beres, P. Littrup et al., Percutaneous imageguided cryoablation of painful metastases involving bone: multicenter trial. Cancer, pp.1033-1074, 2013.

F. Deschamps, G. Farouil, N. Ternes, A. Gaudin, A. Hakime et al., Thermal ablation techniques: a curative treatment of bone metastases in selected patients?, European Radiology, vol.24, issue.8, 2014.
DOI : 10.1016/j.jvir.2012.10.019

B. Mcmenomy, A. Kurup, G. Johnson, R. Carter, R. Mcwilliams et al., Percutaneous Cryoablation of Musculoskeletal Oligometastatic Disease for Complete Remission, Journal of Vascular and Interventional Radiology, vol.24, issue.2, pp.207-220, 2013.
DOI : 10.1016/j.jvir.2012.10.019

M. Havez, N. Lippa, S. Al-ammari, M. Kind, E. Stoeckle et al., Percutaneous Image-Guided Cryoablation in Inoperable Extra-abdominal Desmoid Tumors: A Study of Tolerability and Efficacy, CardioVascular and Interventional Radiology, vol.147, issue.5, pp.1500-1506, 2014.
DOI : 10.1016/j.surg.2009.10.053

J. Schmitz, G. Schmit, T. Atwell, M. Callstrom, A. Kurup et al., Percutaneous Cryoablation of Extraabdominal Desmoid Tumors: A 10-Year Experience, American Journal of Roentgenology, vol.207, issue.1, 2016.
DOI : 10.2214/AJR.15.14391

F. Cornelis, A. Neuville, C. Labrèze, M. Kind, B. Bui et al., Percutaneous Cryotherapy of Vascular Malformation: Initial Experience, CardioVascular and Interventional Radiology, vol.34, issue.1, pp.853-859
DOI : 10.1136/jnnp.34.1.105

S. Thompson, M. Callstrom, M. Mckusick, and D. Woodrum, Initial Results of Image-Guided Percutaneous Ablation as Second-Line Treatment for Symptomatic Vascular Anomalies, CardioVascular and Interventional Radiology, vol.25, issue.11, pp.1171-1179, 2015.
DOI : 10.1016/j.jvir.2014.08.006

M. Callstrom and A. Kurup, Percutaneous ablation for bone and soft tissue metastases--why cryoablation? Skeletal Radiol, pp.835-844, 2009.

J. Hinshaw, M. Lubner, T. Ziemlewicz, F. Lee, and C. Brace, Percutaneous Tumor Ablation Tools: Microwave, Radiofrequency, or Cryoablation???What Should You Use and Why?, RadioGraphics, vol.34, issue.5, 2014.
DOI : 10.1148/rg.345140054

J. Seifert and D. Morris, World Survey on the Complications of Hepatic and Prostate Cryotherapy, World Journal of Surgery, vol.23, issue.2, pp.109-122, 1999.
DOI : 10.1007/PL00013173

S. Kawamoto, S. Solomon, D. Bluemke, and E. Fishman, Computed Tomography and Magnetic Resonance Imaging Appearance of Renal Neoplasms After Radiofrequency Ablation and Cryoablation, Seminars in Ultrasound, CT and MRI, vol.30, issue.2, pp.67-77, 2009.
DOI : 10.1053/j.sult.2008.12.005

J. Garnon, T. Tricard, R. Cazzato, X. Cathelineau, A. Gangi et al., [Percutaneous renal ablation: Pre-, per-, post-interventional evaluation modalities and adapted management]. Progres En Urol J Assoc Francaise Urol Soc Francaise Urol, pp.971-93, 2017.

M. Ahmed, L. Solbiati, C. Brace, D. Breen, M. Callstrom et al., Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update, Radiology, 2014.

R. Lencioni, New Data Supporting Modified RECIST (mRECIST) for Hepatocellular Carcinoma, Clinical Cancer Research, vol.19, issue.6, pp.1312-1316, 2013.
DOI : 10.1158/1078-0432.CCR-12-3796

A. Stein, J. Mayes, V. Mouraviev, V. Chen, R. Nelson et al., Persistent Contrast Enhancement Several Months after Laparoscopic Cryoablation of the Small Renal Mass May Not Indicate Recurrent Tumor, Journal of Endourology, vol.22, issue.11, pp.2433-2442, 2008.
DOI : 10.1089/end.2008.0261

C. Weight, J. Kaouk, N. Hegarty, E. Remer, O. Malley et al., Correlation of Radiographic Imaging and Histopathology Following Cryoablation and Radio Frequency Ablation for Renal Tumors, The Journal of Urology, vol.179, issue.4, pp.1277-81, 2008.
DOI : 10.1016/j.juro.2007.11.075

. Müller, Available from: https://scholar.google.com/scholar_lookup?, 2017.

J. Macfarlane, R. Glasgow, and . Infirmary, Clinical reports of the surgical practice of the Glasgow Royal Infirmary [electronic resource] [Internet]. Glasgow : Printed for David Robertson; 1832. 344 p. Available from: http://archive.org/details/b2146442x 3, Mason JB. DESMOID TUMORS. Ann Surg, vol.92, issue.3, pp.444-53, 1930.

H. Stone and . Iv, DESMOID TUMORS OF THE ABDOMINAL WALL, Annals of Surgery, vol.48, issue.2, pp.175-85, 1908.
DOI : 10.1097/00000658-190808000-00004

A. Stout, Fibrosarcoma the malignant tumor of fibroblasts. Cancer, pp.30-63, 1948.

D. Broekhoven, . Van, D. Grünhagen, M. Bakker, T. Dalen et al., Time Trends in the Incidence and Treatment of Extra-Abdominal and Abdominal Aggressive Fibromatosis: A Population-Based Study, Annals of Surgical Oncology, vol.51, issue.2, pp.2817-2840, 2015.
DOI : 10.1016/j.ejca.2014.11.005

J. Reitamo, P. Häyry, E. Nykyri, and E. Saxén, The Desmoid Tumor. I.: Incidence, Sex-, Age- and Anatomical Distribution in the Finnish Population, American Journal of Clinical Pathology, vol.77, issue.6, pp.665-73, 1982.
DOI : 10.1093/ajcp/77.6.665

N. Penel, J. Coindre, S. Bonvalot, A. Italiano, A. Neuville et al., Management of desmoid tumours: A nationwide survey of labelled reference centre networks in France, European Journal of Cancer, vol.58, pp.90-96, 1990.
DOI : 10.1016/j.ejca.2016.02.008

URL : https://hal.archives-ouvertes.fr/hal-01812682

C. Meazza, G. Bisogno, A. Gronchi, M. Fiore, G. Cecchetto et al., Aggressive fibromatosis in children and adolescents, Cancer, vol.173, issue.1, pp.233-273, 2010.
DOI : 10.5435/00124635-200804000-00002

L. Faulkner, S. Hajdu, U. Kher, L. Quaglia, M. Exelby et al., Pediatric desmoid tumor: retrospective analysis of 63 cases., Journal of Clinical Oncology, vol.13, issue.11, pp.2813-2821, 1995.
DOI : 10.1200/JCO.1995.13.11.2813

S. Salas, A. Dufresne, B. Bui, J. Blay, P. Terrier et al., Prognostic Factors Influencing Progression-Free Survival Determined From a Series of Sporadic Desmoid Tumors: A Wait-and-See Policy According to Tumor Presentation, Journal of Clinical Oncology, vol.29, issue.26, pp.3553-3561, 2011.
DOI : 10.1200/JCO.2010.33.5489

N. Penel, L. Cesne, A. Bonvalot, S. Giraud, A. Bompas et al., Surgical versus non-surgical approach in primary desmoid-type fibromatosis patients: A nationwide prospective cohort from the French Sarcoma Group, European Journal of Cancer, vol.83, pp.125-156, 1990.
DOI : 10.1016/j.ejca.2017.06.017

T. Fallen, M. Wilson, B. Morlan, and N. Lindor, Desmoid Tumors ??? a Characterization of Patients Seen at Mayo Clinic 1976???1999, Familial Cancer, vol.4, issue.3, pp.191-195, 2006.
DOI : 10.1001/archsurg.1979.01370340087015

M. Nieuwenhuis, M. Casparie, L. Mathus-vliegen, O. Dekkers, P. Hogendoorn et al., A nation-wide study comparing sporadic and familial adenomatous polyposis-related desmoid-type fibromatoses, International Journal of Cancer, vol.38, issue.1, pp.256-61, 2011.
DOI : 10.1136/jmg.38.12.861

L. Koskenvuo, A. Ristimäki, and A. Lepistö, Comparison of sporadic and FAP-associated desmoid-type fibromatoses, Journal of Surgical Oncology, vol.95, issue.6, 2017.
DOI : 10.1002/bjs.6241

M. Nieuwenhuis, J. Lefevre, S. Bülow, H. Järvinen, L. Bertario et al., Family History, Surgery, and APC Mutation Are Risk Factors for Desmoid Tumors in Familial Adenomatous Polyposis: An International Cohort Study, Diseases of the Colon & Rectum, vol.54, issue.10, pp.1229-1263, 2011.
DOI : 10.1097/DCR.0b013e318227e4e8

V. Jo and C. Fletcher, WHO classification of soft tissue tumours: an update based on the 2013 (4th) edition. Pathology (Phila) 2014 Feb, pp.95-104

C. Colombo, S. Bolshakov, S. Hajibashi, L. Lopez-terrada, W. Wang et al., mutational analysis, Histopathology, vol.36, issue.2, pp.336-376, 2011.
DOI : 10.1016/j.humpath.2005.03.005

L. Guellec, S. Soubeyran, I. Rochaix, P. Filleron, T. Neuville et al., CTNNB1 mutation analysis is a useful tool for the diagnosis of desmoid tumors: a study of 260 desmoid tumors and 191 potential morphologic mimics, Modern Pathology, vol.126, issue.12, pp.1551-1559, 2012.
DOI : 10.1016/j.humpath.2006.01.017

W. Wang, C. Nero, A. Pappo, D. Lev, and A. Lazar, Screening in Pediatric Desmoid Tumors: A Proposed Algorithm, Pediatric and Developmental Pathology, vol.48, issue.5, pp.361-368, 2012.
DOI : 10.1007/s10350-004-0949-5

K. Skubitz, Biology and Treatment of Aggressive Fibromatosis or Desmoid Tumor, Mayo Clinic Proceedings, vol.92, issue.6, p.2017
DOI : 10.1016/j.mayocp.2017.02.012

F. Kamali, W. Wang, B. Guadagnolo, P. Fox, V. Lewis et al., MRI may be used as a prognostic indicator in patients with extra-abdominal desmoid tumours, The British Journal of Radiology, vol.44, issue.1058, p.20150308, 1058.
DOI : 10.1037/h0037350

M. Sundaram, M. Mcguire, and F. Schajowicz, Soft-tissue masses: histologic basis for decreased signal (short T2) on T2-weighted MR images, American Journal of Roentgenology, vol.148, issue.6, pp.1247-50, 1987.
DOI : 10.2214/ajr.148.6.1247

M. Braschi-amirfarzan, A. Keraliya, K. Krajewski, S. Tirumani, A. Shinagare et al., Role of Imaging in Management of Desmoid-type Fibromatosis: A Primer for Radiologists, RadioGraphics, vol.36, issue.3, pp.767-82, 2016.
DOI : 10.1148/rg.2016150153

M. Khanna, S. Ramanathan, A. Kambal, M. Berawi, S. Yadav et al., Multi-parametric (mp) MRI for the diagnosis of abdominal wall desmoid tumors, European Journal of Radiology, vol.92, pp.103-113
DOI : 10.1016/j.ejrad.2017.04.010

G. Castellazzi, D. Vanel, L. Cesne, A. , L. Pechoux et al., Can the MRI signal of aggressive fibromatosis be used to predict its behavior?, European Journal of Radiology, vol.69, issue.2, pp.222-231, 2009.
DOI : 10.1016/j.ejrad.2008.10.012

J. Vandevenne, D. Schepper, A. , D. Beuckeleer, L. Van-marck et al., New concepts in understanding evolution of desmoid tumors: MR imaging of 30 lesions, European Radiology, vol.7, issue.7, pp.1013-1022, 1997.
DOI : 10.1007/s003300050243

A. Sinha, A. Hansmann, S. Bhandari, A. Gupta, D. Burling et al., Imaging assessment of desmoid tumours in familial adenomatous polyposis: is state-of-the-art 1.5 T MRI better than 64-MDCT?, The British Journal of Radiology, vol.85, issue.1015, 2012.
DOI : 10.2214/ajr.169.2.9242755

A. Brooks, R. Reznek, K. Nugent, K. Farmer, J. Thomson et al., CT appearances of desmoid tumours in familial adenomatous polyposis: Further observations, Clinical Radiology, vol.49, issue.9, pp.601-608, 1994.
DOI : 10.1016/S0009-9260(05)81875-6

M. Murphey, C. Ruble, S. Tyszko, A. Zbojniewicz, B. Potter et al., From the archives of the AFIP: musculoskeletal fibromatoses: radiologic-pathologic correlation, 2009.
DOI : 10.1148/radiographics.19.5.g99se101253

J. Rhim, J. Kim, K. Moon, S. Park, C. Sohn et al., Desmoid-type fibromatosis in the head and neck: CT and MR imaging characteristics, Neuroradiology, vol.6, issue.3, pp.351-360, 2013.
DOI : 10.1002/jmri.22406

R. Milos, T. Moritz, M. Bernathova, G. Amann, J. Panotopoulos et al., Superficial desmoid tumors: MRI and ultrasound imaging characteristics, European Journal of Radiology, vol.84, issue.11, pp.2194-201, 2015.
DOI : 10.1016/j.ejrad.2015.08.012

B. Kasper, C. Baumgarten, J. Garcia, S. Bonvalot, R. Haas et al., An update on the management of sporadic desmoid-type fibromatosis: a European Consensus Initiative between Sarcoma PAtients EuroNet (SPAEN) and European Organization for Research and Treatment of Cancer (EORTC)/Soft Tissue and Bone Sarcoma Group (STBSG), Annals of Oncology, vol.18, issue.4, pp.2399-408, 2017.
DOI : 10.1634/theoncologist.2012-0449

C. Colombo, R. Miceli, L. Péchoux, C. Palassini, E. Honoré et al., Sporadic extra abdominal wall desmoid-type fibromatosis: Surgical resection can be safely limited to a minority of patients, European Journal of Cancer, vol.51, issue.2, pp.186-92, 1990.
DOI : 10.1016/j.ejca.2014.11.019

S. Bonvalot, N. Ternès, M. Fiore, G. Bitsakou, C. Colombo et al., Spontaneous Regression of Primary Abdominal Wall Desmoid Tumors: More Common than Previously Thought, Annals of Surgical Oncology, vol.173, issue.Suppl 10, pp.4096-102, 2013.
DOI : 10.2353/ajpath.2008.080475

M. Fiore, F. Rimareix, L. Mariani, J. Domont, P. Collini et al., Desmoid-Type Fibromatosis: A Front-Line Conservative Approach to Select Patients for Surgical Treatment, Annals of Surgical Oncology, vol.173, issue.9, pp.2587-93, 2009.
DOI : 10.1016/j.ijrobp.2007.10.013

A. Crago, B. Denton, S. Salas, A. Dufresne, J. Mezhir et al., A Prognostic Nomogram for Prediction of Recurrence in Desmoid Fibromatosis, Annals of Surgery, vol.258, issue.2, pp.347-53, 2013.
DOI : 10.1097/SLA.0b013e31828c8a30

E. Stoeckle, J. Coindre, M. Longy, M. Binh, G. Kantor et al., A critical analysis of treatment strategies in desmoid tumours: a review of a series of 106 cases, European Journal of Surgical Oncology (EJSO), vol.35, issue.2, pp.129-163, 2009.
DOI : 10.1016/j.ejso.2008.06.1495

M. Janssen, D. Van-broekhoven, J. Cates, W. Bramer, J. Nuyttens et al., Meta-analysis of the influence of surgical margin and adjuvant radiotherapy on local recurrence after resection of sporadic desmoid-type fibromatosis, British Journal of Surgery, vol.86, issue.4, pp.347-57, 2017.
DOI : 10.1002/jso.20057

P. Rigaux, D. Lefebvre-kuntz, N. Penel, and . Sos-desmoïde, Pain burden in desmoid tumor patients: A survey of the French Advocacy Group SOS Desmoid, Bulletin du Cancer, vol.102, issue.3, pp.213-219, 2015.
DOI : 10.1016/j.bulcan.2015.02.001

M. Emori, M. Kaya, T. Mitsuhashi, H. Asanuma, and T. Yamashita, Desmoid tumor-associated pain is dependent on mast cell expression of cyclooxygenase-2, Diagnostic Pathology, vol.9, issue.1, p.14, 2014.
DOI : 10.1073/pnas.232422999

URL : https://diagnosticpathology.biomedcentral.com/track/pdf/10.1186/1746-1596-9-14?site=diagnosticpathology.biomedcentral.com

S. Hamada, N. Futamura, K. Ikuta, H. Urakawa, E. Kozawa et al., CTNNB1 S45F Mutation Predicts Poor Efficacy of Meloxicam Treatment for Desmoid Tumors: A Pilot Study, PLoS ONE, vol.50, issue.5, p.96391, 2014.
DOI : 10.1371/journal.pone.0096391.t003

URL : https://doi.org/10.1371/journal.pone.0096391

D. Quast, R. Schneider, E. Burdzik, S. Hoppe, and G. Möslein, Long-term outcome of sporadic and FAP-associated desmoid tumors treated with high-dose selective estrogen receptor modulators and sulindac: a single-center long-term observational study in 134 patients, Familial Cancer, vol.18, issue.9, pp.31-40, 2016.
DOI : 10.1634/theoncologist.2012-0449

S. Skapek, J. Anderson, D. Hill, D. Henry, S. Spunt et al., Safety and efficacy of high-dose tamoxifen and sulindac for desmoid tumor in children: Results of a Children's Oncology Group (COG) Phase II Study, Pediatric Blood & Cancer, vol.29, issue.7, pp.1108-1120, 2013.
DOI : 10.1200/JCO.2010.33.5489

M. Fiore, C. Colombo, S. Radaelli, D. Callegaro, E. Palassini et al., Hormonal manipulation with toremifene in sporadic desmoid-type fibromatosis, European Journal of Cancer, vol.51, issue.18, pp.2800-2807, 1990.
DOI : 10.1016/j.ejca.2015.08.026

E. Palassini, A. Frezza, L. Mariani, L. Lalli, C. Colombo et al., Long-term Efficacy of Methotrexate Plus Vinblastine/Vinorelbine in a Large Series of Patients Affected by Desmoid-Type Fibromatosis, The Cancer Journal, vol.23, issue.2, pp.86-91
DOI : 10.1097/PPO.0000000000000254

A. Azzarelli, A. Gronchi, R. Bertulli, J. Tesoro, D. Baratti et al., Low-dose chemotherapy with methotrexate and vinblastine for patients with advanced aggressive fibromatosis. Cancer, pp.1259-64, 2001.

P. Ananth, A. Werger, S. Voss, C. Rodriguez-galindo, and K. Janeway, Liposomal doxorubicin: Effective treatment for pediatric desmoid fibromatosis. Pediatr Blood Cancer, 2017.

A. Constantinidou, R. Jones, M. Scurr, O. Al-muderis, and J. I. , Pegylated liposomal doxorubicin, an effective, well-tolerated treatment for refractory aggressive fibromatosis, European Journal of Cancer, vol.45, issue.17, pp.2930-2934, 1990.
DOI : 10.1016/j.ejca.2009.08.016

N. Penel, L. Cesne, A. Bui, B. Perol, D. Brain et al., Imatinib for progressive and recurrent aggressive fibromatosis (desmoid tumors): an FNCLCC/French Sarcoma Group phase II trial with a long-term follow-up, Annals of Oncology, vol.23, issue.29, pp.452-459, 2011.
DOI : 10.1200/JCO.2005.02.8712

B. Kasper, V. Gruenwald, P. Reichardt, S. Bauer, G. Rauch et al., Imatinib induces sustained progression arrest in RECIST progressive desmoid tumours: Final results of a phase II study of the German Interdisciplinary Sarcoma Group (GISG), European Journal of Cancer, vol.76, pp.60-67, 1990.
DOI : 10.1016/j.ejca.2017.02.001

R. Chugh, J. Wathen, S. Patel, R. Maki, P. Meyers et al., Efficacy of imatinib in aggressive fibromatosis: Results of a phase II multicenter Sarcoma Alliance for Research through Collaboration (SARC) trial. Clin Cancer Res Off J Am Assoc Cancer Res, pp.4884-91, 2010.

B. Kasper, V. Gruenwald, P. Reichardt, S. Bauer, P. Hohenberger et al., Correlation of CTNNB1 Mutation Status with Progression Arrest Rate in RECIST Progressive Desmoid-Type Fibromatosis Treated with Imatinib: Translational Research Results from a Phase 2 Study of the German Interdisciplinary Sarcoma Group (GISG-01), Annals of Surgical Oncology, vol.17, issue.suppl 4, pp.1924-1931, 2016.
DOI : 10.1158/1078-0432.CCR-10-3322

V. Villalobos, F. Hall, A. Jimeno, L. Gore, K. Kern et al., Long-Term Follow-Up of Desmoid Fibromatosis Treated with PF-03084014, an Oral Gamma Secretase Inhibitor, Annals of Surgical Oncology, vol.50, issue.4, pp.768-75, 2018.
DOI : 10.1097/RLI.0000000000000123

S. Kummar, O. Coyne, G. Do, K. Turkbey, B. Meltzer et al., Clinical Activity of the ??-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors (Aggressive Fibromatosis), Journal of Clinical Oncology, vol.35, issue.14, pp.1561-1570, 2017.
DOI : 10.1200/JCO.2016.71.1994

R. Keus, R. Nout, J. Blay, J. Jong, I. Hennig et al., Results of a phase II pilot study of moderate dose radiotherapy for inoperable desmoid-type fibromatosis--an EORTC STBSG and ROG study (EORTC 62991-22998), Annals of Oncology, vol.9, issue.4, 22998.
DOI : 10.1586/era.09.9

, Ann Oncol Off J Eur Soc Med Oncol, vol.24, issue.10, pp.2672-2678, 2013.

S. Bonvalot, M. Rivoire, M. Castaing, E. Stoeckle, L. Cesne et al., Primary Retroperitoneal Sarcomas: A Multivariate Analysis of Surgical Factors Associated With Local Control, Journal of Clinical Oncology, vol.27, issue.1, pp.31-38, 2009.
DOI : 10.1200/JCO.2008.18.0802

D. Van-broekhoven, J. Deroose, S. Bonvalot, A. Gronchi, D. Grünhagen et al., Isolated limb perfusion using tumour necrosis factor ?? and melphalan in patients with advanced aggressive fibromatosis, British Journal of Surgery, vol.119, issue.13, pp.1674-80, 2014.
DOI : 10.1002/cncr.28271

D. Grünhagen, J. De-wilt, C. Verhoef, A. Van-geel, and A. Eggermont, TNF-based isolated limb perfusion in unresectable extremity desmoid tumours, European Journal of Surgical Oncology (EJSO), vol.31, issue.8, 2005.
DOI : 10.1016/j.ejso.2005.07.002

J. Deroose, A. Eggermont, A. Van-geel, J. Burger, M. Den-bakker et al., Long-Term Results of Tumor Necrosis Factor ????? and Melphalan-Based Isolated Limb Perfusion in Locally Advanced Extremity Soft Tissue Sarcomas, Journal of Clinical Oncology, vol.29, issue.30, pp.4036-4080, 2011.
DOI : 10.1200/JCO.2011.35.6618

J. Kujak, P. Liu, G. Johnson, and M. Callstrom, Early experience with percutaneous cryoablation of extra-abdominal desmoid tumors, Skeletal Radiology, vol.189, issue.2, pp.175-82, 2010.
DOI : 10.2214/ajr.160.4.8456670

M. Havez, N. Lippa, S. Al-ammari, M. Kind, E. Stoeckle et al., Percutaneous Image-Guided Cryoablation in Inoperable Extra-abdominal Desmoid Tumors: A Study of Tolerability and Efficacy, CardioVascular and Interventional Radiology, vol.147, issue.5, 2014.
DOI : 10.1016/j.surg.2009.10.053

J. Schmitz, G. Schmit, T. Atwell, M. Callstrom, A. Kurup et al., Percutaneous Cryoablation of Extraabdominal Desmoid Tumors: A 10-Year Experience, American Journal of Roentgenology, vol.207, issue.1, pp.190-195
DOI : 10.2214/AJR.15.14391

B. Kasper, A. Dimitrakopoulou-strauss, L. Pilz, L. Strauss, C. Sachpekidis et al., Positron emission tomography as a surrogate marker for evaluation of treatment response in patients with desmoid tumors under therapy with imatinib Descriptive epidemiology of sarcomas in Europe: report from the RARECARE project, BioMed Res Int. Eur J Cancer Oxf Engl Feb, vol.201349, issue.3, pp.684-95, 1990.

F. Ducimetière, A. Lurkin, D. Ranchère-vince, A. Decouvelaere, M. Péoc-'h et al., Incidence of Sarcoma Histotypes and Molecular Subtypes in a Prospective Epidemiological Study with Central Pathology Review and Molecular Testing, PLoS ONE, vol.36, issue.8, p.20294, 2011.
DOI : 10.1371/journal.pone.0020294.t009

P. Cassier, F. Ducimetière, A. Lurkin, D. Ranchère-vince, J. Scoazec et al., A prospective epidemiological study of new incident GISTs during two consecutive years in Rh??ne Alpes region: incidence and molecular distribution of GIST in a European region, British Journal of Cancer, vol.25, issue.2, pp.165-70, 2010.
DOI : 10.1002/cncr.20862

N. Penel, J. Coindre, G. A. Terrier, P. Ranchere-vince, D. Collin et al., Presentation and outcome of frequent and rare sarcoma histologic subtypes: A study of 10,262 patients with localized visceral/soft tissue sarcoma managed in reference centers, Cancer, vol.27, issue.suppl 6, 2017.
DOI : 10.1200/JCO.2015.60.8505

V. Jo and C. Fletcher, WHO classification of soft tissue tumours: an update based on the 2013 (4th) edition. Pathology (Phila) 2014 Feb, pp.95-104

M. Trojani, G. Contesso, J. Coindre, J. Rouesse, N. Bui et al., Soft-tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system, International Journal of Cancer, vol.2, issue.1, pp.37-42, 1984.
DOI : 10.1002/ijc.2910330108

J. Coindre, Molecular biology of soft-tissue sarcomas], Bull Cancer, 2010.

I. Ray-coquard, M. Montesco, J. Coindre, D. Tos, A. Lurkin et al., Sarcoma: concordance between initial diagnosis and centralized expert review in a population-based study within three European regions, Annals of Oncology, vol.26, issue.5, 2012.
DOI : 10.1200/JCO.2008.16.4061

N. Lindor, M. Mcmaster, C. Lindor, and M. Greene, National Cancer Institute, Division of Cancer Prevention, Community Oncology and Prevention Trials Research Group. Concise handbook of familial cancer susceptibility syndromes -second edition, J Natl Cancer Inst Monogr, issue.38, pp.1-93, 2008.

P. Temming, M. Arendt, A. Viehmann, L. Eisele, L. Guin et al., Incidence of second cancers after radiotherapy and systemic chemotherapy in heritable retinoblastoma survivors: A report from the German reference center. Pediatr Blood Cancer, 2017.

, Risk of Soft-Tissue Sarcoma Among 69 460 Five-Year Survivors of Childhood Cancer in Europe, 29165710.

R. Ferner and D. Gutmann, International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis, Cancer Res, vol.62, issue.5, pp.1573-1580, 2002.

O. Brien, M. Donaldson, S. Balise, R. Whittemore, A. Link et al., Second malignant neoplasms in survivors of pediatric Hodgkin's lymphoma treated with low-dose radiation and chemotherapy

, J Clin Oncol Off J Am Soc Clin Oncol, vol.28, issue.7, pp.1232-1241, 2010.

T. Group, Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Ann Oncol, vol.25, issue.3, pp.102-114, 2009.

M. Kransdorf and M. Murphey, Radiologic Evaluation of Soft-Tissue Masses, American Journal of Roentgenology, vol.175, issue.3, pp.575-87, 2000.
DOI : 10.2214/ajr.175.3.1750575

M. Kransdorf and M. Murphey, Imaging of Soft-Tissue Musculoskeletal Masses: Fundamental Concepts, RadioGraphics, vol.36, issue.6, pp.1931-1979, 2016.
DOI : 10.1148/rg.2016160084

C. Van-rijswijk, M. Geirnaerdt, P. Hogendoorn, A. Taminiau, F. Van-coevorden et al., Soft-Tissue Tumors: Value of Static and Dynamic Gadopentetate Dimeglumine???enhanced MR Imaging in Prediction of Malignancy, Radiology, vol.233, issue.2, 2004.
DOI : 10.1148/radiol.2332031110

T. Berquist, R. Ehman, B. King, C. Hodgman, and D. Ilstrup, Value of MR imaging in differentiating benign from malignant soft-tissue masses: study of 95 lesions., American Journal of Roentgenology, vol.155, issue.6, pp.1251-1256, 1990.
DOI : 10.2214/ajr.155.6.2122675

J. Crim, L. Seeger, L. Yao, V. Chandnani, and J. Eckardt, Diagnosis of soft-tissue masses with MR imaging: can benign masses be differentiated from malignant ones?, Radiology, vol.185, issue.2, 1992.
DOI : 10.1148/radiology.185.2.1410377

URL : https://cloudfront.escholarship.org/dist/prd/content/qt9gd6c519/qt9gd6c519.pdf

M. Kind, N. Stock, and J. Coindre, Histology and imaging of soft tissue sarcomas, European Journal of Radiology, vol.72, issue.1, pp.6-15, 2009.
DOI : 10.1016/j.ejrad.2009.05.023

M. Kransdorf, L. Bancroft, J. Peterson, M. Murphey, W. Foster et al., Imaging of Fatty Tumors: Distinction of Lipoma and Well-differentiated Liposarcoma, Radiology, vol.224, issue.1, 2002.
DOI : 10.1148/radiol.2241011113

J. Wu and M. Hochman, Soft-Tissue Tumors and Tumorlike Lesions: A Systematic Imaging Approach, Radiology, vol.253, issue.2, pp.297-316, 2009.
DOI : 10.1148/radiol.2532081199

A. Crombe, N. Alberti, E. Stoeckle, V. Brouste, X. Buy et al., Soft tissue masses with myxoid stroma: Can conventional magnetic resonance imaging differentiate benign from malignant tumors?, European Journal of Radiology, vol.85, issue.10, pp.1875-82, 2016.
DOI : 10.1016/j.ejrad.2016.08.015

F. Zhao, S. Ahlawat, S. Farahani, K. Weber, E. Montgomery et al., Can MR imaging be used to predict tumor grade in soft-tissue sarcoma? Radiology, pp.192-201, 2014.
DOI : 10.1148/radiol.14131871

T. Soldatos, S. Ahlawat, E. Montgomery, M. Chalian, M. Jacobs et al., Multiparametric Assessment of Treatment Response in High-Grade Soft-Tissue Sarcomas with Anatomic and Functional MR Imaging Sequences, Radiology, vol.278, issue.3, pp.831-871, 2016.
DOI : 10.1148/radiol.2015142463

D. Berger-richardson and C. Swallow, Needle tract seeding after percutaneous biopsy of sarcoma: Risk/benefit considerations, Cancer, vol.12, issue.suppl 2, pp.560-567, 2017.
DOI : 10.1111/ajco.12125

W. Van-houdt, A. Schrijver, R. Cohen-hallaleh, N. Memos, N. Fotiadis et al., Needle tract seeding following core biopsies in retroperitoneal sarcoma, European Journal of Surgical Oncology (EJSO), vol.43, issue.9, pp.1740-1745, 2017.
DOI : 10.1016/j.ejso.2017.06.009

M. Siddiqi, H. Kim, F. Jede, and I. Han, Association of core needle biopsy tract resection with local recurrence in extremity soft tissue sarcoma, Skeletal Radiology, vol.72, issue.300, pp.507-519
DOI : 10.1245/ASO.2005.03.045

J. Blay, P. Soibinet, N. Penel, E. Bompas, F. Duffaud et al., Improved survival using specialized multidisciplinary board in sarcoma patients, Annals of Oncology, vol.41, issue.2, pp.2852-2861, 2017.
DOI : 10.1016/j.ejso.2015.04.002

URL : https://doi.org/10.1093/annonc/mdx484

S. Mathoulin-pélissier, C. Chevreau, C. Bellera, E. Bauvin, M. Savès et al., Adherence to consensus-based diagnosis and treatment guidelines in adult soft-tissue sarcoma patients: a French prospective population-based study???, Annals of Oncology, vol.10, issue.1, pp.225-256, 2014.
DOI : 10.1186/1471-2458-10-188

J. Gutierrez, E. Perez, F. Moffat, A. Livingstone, D. Franceschi et al., Should soft tissue sarcomas be treated at high-volume centers? An analysis of 4205 patients, Ann Surg, 2007.
DOI : 10.1097/01.sla.0000250438.04393.a8

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1876958

E. Stoeckle, A. Michot, L. Rigal, F. Babre, P. Sargos et al., The risk of postoperative complications and functional impairment after multimodality treatment for limb and trunk wall soft-tissue sarcoma: Long term results from a monocentric series, European Journal of Surgical Oncology (EJSO), vol.43, issue.6, pp.20171117-20171142
DOI : 10.1016/j.ejso.2017.01.018

P. Pisters, L. Harrison, D. Leung, J. Woodruff, E. Casper et al., Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma., Journal of Clinical Oncology, vol.14, issue.3, pp.859-68, 1996.
DOI : 10.1200/JCO.1996.14.3.859

J. Beane, J. Yang, D. White, S. Steinberg, S. Rosenberg et al., Efficacy of Adjuvant Radiation Therapy in the Treatment of Soft Tissue Sarcoma of the Extremity: 20-year Follow-Up of a Randomized Prospective Trial, Annals of Surgical Oncology, vol.116, issue.8, pp.2484-2493, 2014.
DOI : 10.1002/cncr.24949

E. Stoeckle, A. Michot, B. Henriques, P. Sargos, C. Honoré et al., Surgery for soft-tissue sarcomas of the limbs and trunk wall], Cancer Radiother J Soc Francaise Radiother Oncol, 2016.

E. Stoeckle, J. Coindre, M. Kind, G. Kantor, and B. Bui, Evaluating surgery quality in soft tissue sarcoma. Recent Results Cancer Res Fortschritte Krebsforsch Progres Dans Rech Sur Cancer, pp.229-271, 2009.

A. Gronchi, D. Strauss, R. Miceli, S. Bonvalot, C. Swallow et al., Patterns of Recurrence After Resection of Primary Retroperitoneal Sarcoma (RPS): A Report on 1007 Patients From the Multi-institutional Collaborative RPS Working Group. Ann Surg, 2016.

S. Bonvalot, M. Rivoire, M. Castaing, E. Stoeckle, L. Cesne et al., Primary Retroperitoneal Sarcomas: A Multivariate Analysis of Surgical Factors Associated With Local Control, Journal of Clinical Oncology, vol.27, issue.1, pp.31-38, 2009.
DOI : 10.1200/JCO.2008.18.0802

E. Stoeckle, H. Gardet, J. Coindre, G. Kantor, F. Bonichon et al., Prospective evaluation of quality of surgery in soft tissue sarcoma, European Journal of Surgical Oncology (EJSO), vol.32, issue.10, pp.1242-1250, 2006.
DOI : 10.1016/j.ejso.2006.05.005

O. Cahlon, M. Brennan, X. Jia, L. Qin, S. Singer et al., A Postoperative Nomogram for Local Recurrence Risk in Extremity Soft Tissue Sarcomas After Limb-Sparing Surgery Without Adjuvant Radiation, Annals of Surgery, vol.255, issue.2, pp.343-350, 2012.
DOI : 10.1097/SLA.0b013e3182367aa7

URL : http://europepmc.org/articles/pmc5016830?pdf=render

A. Gronchi, R. Miceli, E. Shurell, F. Eilber, F. Eilber et al., Outcome Prediction in Primary Resected Retroperitoneal Soft Tissue Sarcoma: Histology-Specific Overall Survival and Disease-Free Survival Nomograms Built on Major Sarcoma Center Data Sets, Journal of Clinical Oncology, vol.31, issue.13, pp.311649-55, 2013.
DOI : 10.1200/JCO.2012.44.3747

J. Deroose, A. Eggermont, A. Van-geel, J. Burger, M. Den-bakker et al., Long-term results of tumor necrosis factor alpha-and melphalan-based isolated limb perfusion in locally advanced extremity soft tissue sarcomas, J Clin Oncol Off J Am Soc Clin Oncol, 2011.

, Oct, vol.2029, issue.30, pp.4036-4080

N. Pervaiz, N. Colterjohn, F. Farrokhyar, R. Tozer, A. Figueredo et al., A systematic metaanalysis of randomized controlled trials of adjuvant chemotherapy for localized resectable softtissue sarcoma. Cancer, pp.573-81, 2008.

E. Stoeckle, G. Kantor, L. Thomas, J. Coindre, and B. Bui, [Surgery of recurrent soft tissue sarcoma of the extremities and the trunk wall: a comparison to primary sarcoma], Bull Cancer, vol.91, issue.11, pp.853-60, 2004.

A. Stojadinovic, D. Leung, P. Allen, J. Lewis, D. Jaques et al., Primary Adult Soft Tissue Sarcoma: Time-Dependent Influence of Prognostic Variables, Journal of Clinical Oncology, vol.20, issue.21, pp.4344-52, 2002.
DOI : 10.1200/JCO.2002.07.154

A. Daigeler, I. Zmarsly, T. Hirsch, O. Goertz, H. Steinau et al., Long-term outcome after local recurrence of soft tissue sarcoma: a retrospective analysis of factors predictive of survival in 135 patients with locally recurrent soft tissue sarcoma, British Journal of Cancer, vol.90, issue.6, pp.1456-64, 2014.
DOI : 10.1002/cncr.11365

R. Trans-atlantic and . Group, Management of Recurrent Retroperitoneal Sarcoma (RPS) in the Adult: A Consensus Approach from the Trans-Atlantic RPS Working Group, Annals of Surgical Oncology, vol.14, issue.6, pp.3531-3571, 2016.
DOI : 10.1586/14737140.2014.885840

J. Yang, S. Kong, H. Ahn, H. Lee, S. Jeong et al., Prognostic factors for reoperation of recurrent retroperitoneal sarcoma: The role of clinicopathological factors other than histologic grade, Journal of Surgical Oncology, vol.210, issue.2, pp.165-72, 2015.
DOI : 10.1016/j.jamcollsurg.2009.12.024

J. Park, L. Qin, F. Prete, C. Antonescu, M. Brennan et al., Predicting Outcome by Growth Rate of Locally Recurrent Retroperitoneal Liposarcoma, Annals of Surgery, vol.250, issue.6, pp.977-82, 2009.
DOI : 10.1097/SLA.0b013e3181b2468b

N. Ikoma, C. Roland, K. Torres, Y. Chiang, W. Wang et al., Salvage Surgery for Recurrent Retroperitoneal Well-Differentiated Liposarcoma: Early Reoperation may not Provide Benefit, Annals of Surgical Oncology, vol.27, issue.1, 2018.
DOI : 10.1200/JCO.2008.18.7138

N. Chudgar, M. Brennan, R. Munhoz, P. Bucciarelli, K. Tan et al., Pulmonary metastasectomy with therapeutic intent for soft-tissue sarcoma, The Journal of Thoracic and Cardiovascular Surgery, vol.154, issue.1, 2017.
DOI : 10.1016/j.jtcvs.2017.02.061

U. Pastorino, M. Buyse, G. Friedel, R. Ginsberg, P. Girard et al., Long-term results of lung metastasectomy: Prognostic analyses based on 5206 cases, The Journal of Thoracic and Cardiovascular Surgery, vol.113, issue.1, 1997.
DOI : 10.1016/S0022-5223(97)70397-0

P. Navarria, A. Ascolese, L. Cozzi, S. Tomatis, D. Agostino et al., Stereotactic body radiation therapy for lung metastases from soft tissue sarcoma, European Journal of Cancer, vol.51, issue.5, pp.668-74, 1990.
DOI : 10.1016/j.ejca.2015.01.061

J. Palussière, A. Italiano, E. Descat, S. Ferron, F. Cornélis et al., Sarcoma Lung Metastases Treated with Percutaneous Radiofrequency Ablation: Results from 29 Patients, Annals of Surgical Oncology, vol.117, issue.Suppl. 2, pp.3771-3778, 2011.
DOI : 10.1002/cncr.25538

T. De-baère, A. Aupérin, F. Deschamps, P. Chevallier, Y. Gaubert et al., Radiofrequency ablation is a valid treatment option for lung metastases: experience in 566 patients with 1037 metastases, Annals of Oncology, vol.9, issue.5, pp.987-91
DOI : 10.1016/S1470-2045(08)70155-4

I. Judson, J. Verweij, H. Gelderblom, J. Hartmann, P. Schöffski et al., Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial, The Lancet Oncology, vol.15, issue.4, pp.415-438
DOI : 10.1016/S1470-2045(14)70063-4

M. Savina, L. Cesne, A. Blay, J. Ray-coquard, I. Mir et al., Patterns of care and outcomes of patients with METAstatic soft tissue SARComa in a real-life setting: the METASARC observational study, BMC Medicine, vol.342, issue.Suppl, p.78, 2017.
DOI : 10.1056/NEJM200006223422506

C. Esmo-guidelines, Appendix 3: Soft tissue sarcoma: MCBS eUpdate published online 5 May 2017(www.esmo.org/Guidelines/Sarcoma-and-GIST), Annals of Oncology, vol.26, issue.suppl_4, pp.147-155, 2017.
DOI : 10.1093/annonc/mdv249

C. Coens, W. Van-der-graaf, J. Blay, S. Chawla, J. I. Sanfilippo et al., Health-related quality-of-life results from PALETTE: A randomized, double-blind, phase 3 trial of pazopanib versus placebo in patients with soft tissue sarcoma whose disease has progressed during or after prior chemotherapy-a European Organization for research and treatment of cancer soft tissue and bone sarcoma group global network study (EORTC 62072). Cancer, pp.2933-2974, 2015.

W. Tap, R. Jones, B. Van-tine, B. Chmielowski, A. Elias et al., Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial, The Lancet, vol.388, issue.10043, pp.488-97, 2016.
DOI : 10.1016/S0140-6736(16)30587-6

URL : http://europepmc.org/articles/pmc5647653?pdf=render

W. Van-der-graaf, J. Blay, S. Chawla, D. Kim, B. Bui-nguyen et al., Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial, The Lancet, vol.379, issue.9829, pp.1879-86, 2012.
DOI : 10.1016/S0140-6736(12)60651-5

A. Falk, L. Moureau-zabotto, M. Ouali, N. Penel, A. Italiano et al., Effect on Survival of Local Ablative Treatment of Metastases from Sarcomas: A Study of the French Sarcoma Group, Clinical Oncology, vol.27, issue.1, pp.48-55
DOI : 10.1016/j.clon.2014.09.010

S. Thompson, J. Schmitz, G. Schmit, M. Callstrom, and A. Kurup, Image-Guided Thermal Ablative Therapies in the Treatment of Sarcoma, Current Treatment Options in Oncology, vol.27, issue.1, p.25
DOI : 10.1016/j.clon.2014.09.010

J. Xu, J. Li, X. Zhou, J. Zeng, F. Yao et al., Cryotherapy for local recurrent dermatofibrosarcoma protuberans: Experience in 19 patients, Cryobiology, vol.68, issue.1, 2014.
DOI : 10.1016/j.cryobiol.2014.01.009

, Feb, vol.68, issue.1, pp.134-142

W. Fan, L. Niu, Y. Wang, Y. Zhang, X. Yao et al., Percutaneous computed tomography-guided cryoablation for recurrent retroperitoneal soft tissue sarcoma: a study of safety and efficacy, Oncotarget, vol.7, issue.27, pp.42639-42688, 2016.
DOI : 10.18632/oncotarget.9476

Y. Egashira, S. Singh, S. Bandula, and R. Illing, Percutaneous High-Energy Microwave Ablation for the Treatment of Pulmonary Tumors: A Retrospective Single-Center Experience, Journal of Vascular and Interventional Radiology, vol.27, issue.4, pp.474-483
DOI : 10.1016/j.jvir.2016.01.001

T. Sato, T. Iguchi, T. Hiraki, H. Gobara, H. Fujiwara et al., Radiofrequency ablation of pulmonary metastases from sarcoma: single-center retrospective evaluation of 46 patients, Japanese Journal of Radiology, vol.33, issue.2, pp.61-68, 2017.
DOI : 10.1007/s00270-009-9730-4

C. Koelblinger, S. Strauss, and A. Gillams, Outcome after Radiofrequency Ablation of Sarcoma Lung Metastases, CardioVascular and Interventional Radiology, vol.82, issue.1, pp.147-53, 2014.
DOI : 10.1016/j.ijrobp.2010.11.052

H. Yashiro, S. Nakatsuka, M. Inoue, M. Kawamura, N. Tsukada et al., Factors Affecting Local Progression after Percutaneous Cryoablation of Lung Tumors, Journal of Vascular and Interventional Radiology, vol.24, issue.6, pp.813-834
DOI : 10.1016/j.jvir.2012.12.026

P. Littrup, H. Aoun, B. Adam, M. Krycia, M. Prus et al., Percutaneous cryoablation of hepatic tumors: long-term experience of a large U.S. series, Abdominal Radiology, vol.20, issue.176???181, pp.767-80, 2016.
DOI : 10.1016/j.rpor.2014.10.002

A. Hakimé, L. Cesne, A. Deschamps, F. Farouil, G. Boudabous et al., A Role for Adjuvant RFA in Managing Hepatic Metastases from Gastrointestinal Stromal Tumors (GIST) After Treatment with Targeted Systemic Therapy Using Kinase Inhibitors, CardioVascular and Interventional Radiology, vol.26, issue.Suppl, pp.132-141, 2014.
DOI : 10.1097/01.sla.0000242710.36384.1b

R. Jones, J. Mccall, A. Adam, O. Donnell, D. Ashley et al., Radiofrequency ablation is a feasible therapeutic option in the multi modality management of sarcoma, European Journal of Surgical Oncology (EJSO), vol.36, issue.5, pp.477-82, 2010.
DOI : 10.1016/j.ejso.2009.12.005

URL : https://hal.archives-ouvertes.fr/hal-00594805

P. Littrup, H. Bang, B. Currier, D. Goodrich, H. Aoun et al., Soft-Tissue Cryoablation in Diffuse Locations: Feasibility and Intermediate Term Outcomes, Journal of Vascular and Interventional Radiology, vol.24, issue.12, pp.1817-1842, 2013.
DOI : 10.1016/j.jvir.2013.06.025

G. Gravel, S. Yevich, L. Tselikas, O. Mir, C. Teriitehau et al., Percutaneous thermal ablation: A new treatment line in the multidisciplinary management of metastatic leiomyosarcoma?, European Journal of Surgical Oncology (EJSO), vol.43, issue.1, 2017.
DOI : 10.1016/j.ejso.2016.06.391